In cancer, although E-cadherin downregulation is associated with beta-catenin nuclear localization and increasing β-catenin/TCF transcriptional activity, several reports do not support such correlation and β-catenin signaling requires additional events to assure its activation [94]. This evidence concerns the gene HNF4A and cancer.